OUR STORY
Our Vision
Our vision is to be a leader in identifying, developing and commercializing novel drugs that address unmet needs of people with rare cancer conditions.
Learn more about us:
EXHIBITION
Meet us at RSNA in Chicago
November 28 – December 2
Ascelia Pharma will be at the world’s largest radiology conference RSNA in Chicago.
On 1st December, Dr. Kohkan Shamsi will present the abstract for Orviglance comparison study to gadolinium.
Upcoming Events
Latest News
Presentations
INVESTOR